Zinc lozenges vs the common cold: what 17 pooled trials really found
- Claim
- ZINC VS THE COMMON COLD
- Catch
- TRIALS DISAGREE
- Verdict
- THE CATCH SCIENCE
Zinc lozenges are one of the few cold remedies with randomized-trial backing. A 2012 systematic review and meta-analysis in CMAJ (Science et al., 17 trials, 2,121 participants, DOI 10.1503/cmaj.111990) found zinc shortened cold symptoms by about 1.65 days overall — nearly 2.6 days in adults — but no significant effect in children, and the trials disagreed substantially (heterogeneity I² up to 95%). Zinc also came with side effects: bad taste was about 65% more common (RR 1.65) and nausea about 64% more common (RR 1.64) than placebo. Timing matters: government reviews (NCCIH; NIH ODS) note the effect shows up when oral zinc lozenges are started within 24 hours of symptoms and continued for up to two weeks. A 2024 Cochrane review (zinc for prevention and treatment of the common cold) pooled 8 treatment trials (~972 participants) and found about a 2.4-day reduction — but rated it low-certainty evidence, and found little benefit for prevention or in children. The catch: this is "may shorten," not a cure, it needs to start within about a day, and intranasal zinc products must be avoided — they have caused permanent loss of smell, and the FDA has warned about them. Check with a doctor or pharmacist before high-dose zinc, since it can interfere with other minerals and medications.
SOURCES
- Science M, Johnstone J, Roth DE, Guyatt G, Loeb M. "Zinc for the treatment of the common cold," CMAJ 2012;184(10):E551-61. DOI: 10.1503/cmaj.111990
- Cochrane (2024), "Zinc for prevention and treatment of the common cold" (Cochrane Database of Systematic Reviews)
- NCCIH, "The Common Cold and Complementary Health Approaches" (updated digest)
- NIH ODS Zinc Fact Sheet for Consumers
For information only, not medical advice. Check with a doctor or pharmacist before starting high-dose zinc supplements.
